• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

First-half results don’t impress Siemens

Article

German technology conglomerate Siemens AG enjoyed healthy revenue growth of 15% for the financial period from October 1997 to June 1998, but the Munich company said it was unhappy with its 5% increase in earnings for the period. Siemens plans to

German technology conglomerate Siemens AG enjoyed healthy revenue growth of 15% for the financial period from October 1997 to June 1998, but the Munich company said it was unhappy with its 5% increase in earnings for the period. Siemens plans to accelerate its restructuring program to bring profit growth to acceptable levels.

Siemens implemented a restructuring last year to improve the company’s profit outlook, divesting noncore businesses and cutting costs in several divisions (SCAN 9/17/98). Earnings growth since then has not met the company’s expectations, however, according to Siemens AG president and CEO Heinrich von Pierer. Siemens will pursue additional moves, such as divestitures and reorganizations, he said.

The company’s Medical Engineering Group was cited as an example of a successful turnaround effort. The division was one of the groups reorganized last year, and costs associated with the effort contributed to a major loss for the unit in 1997. With the restructuring behind it, Medical Engineering turned in double-digit growth and should achieve a profit this year of hundreds of millions of marks, Pierer said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.